-
There are about 19 million new cases of sexually transmitted infections (STIs) annually in the United States, "and they don't just happen to people who are promiscuous or reckless," says Fred Wyand, media and communications manager for the American Social Health Association (ASHA) in Research Triangle Park, NC.
-
Obtaining source patient consent for HIV testing after a bloodborne pathogen exposure might slowly be getting easier. Some states have responded to the Centers for Disease Control and Prevention (CDC) recommendation to make HIV testing a routine part of health care.
-
Below are key pieces of data you should include when presenting senior management with a cost/benefit analysis, recommends Tamara Y. Blow, manager of occupational health services at Philip Morris USA:
-
This is a three-part series on using financial data to demonstrate the value of occupational health programs. This month, we report on how to demonstrate cost savings to your employer and give a checklist of data you should present.
-
-
In what could be a boon for infection surveillance and treatment programs, the Food and Drug Administration (FDA) has approved a new rapid test for methicillin-resistant Staphylococcus aureus (MRSA) that can identify the bug in two hours.
-
Dishes are churning in the dishwasher, metal utensils are clanging against pots, the radio is blaring, and someone is running the blender and an electric can opener. The noises in a kitchen can be a cacophony as loud as a rock concert. But do they add up to an occupational hazard?
-
The controversy of the past few years over possible suicidality associated with various drugs pointed out the importance of tracking suicidal thoughts or behavior in subjects involved in clinical trials.
-
Giving children a chance to assent to their own participation in research is an important goal of the pediatric research community. Done properly, it can empower young patients, help them develop their decision-making skills, and prompt them to take their participation more seriously.
-
An Institute of Medicine (IOM) committee studying the effects of the HIPAA Privacy Rule has painstakingly documented the strain it is putting on research.